|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,627.50 SEK | -0.34% |
|
-1.36% | -4.46% |
| 07-31 | EU Approves AstraZeneca and Daiichi Sankyo's Datroway for First-Line Triple-Negative Breast Cancer | MT |
| 07-31 | Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,030B | |||||
| 617B | |||||
| 455B | |||||
| 350B | |||||
| 299B |
Select your edition
All financial news and data tailored to specific country editions
